ethinyl estradiol has been researched along with flutamide in 48 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.08) | 18.7374 |
| 1990's | 4 (8.33) | 18.2507 |
| 2000's | 24 (50.00) | 29.6817 |
| 2010's | 18 (37.50) | 24.3611 |
| 2020's | 1 (2.08) | 2.80 |
| Authors | Studies |
|---|---|
| Collini, MD; Dinh, T; Gunawan, I; Harris, HA; Henderson, RA; Keith, JC; Malamas, MS; Manas, ES; McDevitt, RE; Miller, CP; Xu, ZB | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Bellavance, E; Luu-The, V; Poirier, D | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Honda, K; Izumi, T; Miyaji, Y; Nakayama, S; Okazaki, O; Okudaira, N; Shiosakai, K; Sugiyama, D; Suzuki, W; Takakusa, H; Watanabe, A | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Messiha, FS | 1 |
| Aglianò, A; Cianci, A; Ciotta, L; Marletta, E; Palumbo, G; Pisana, L | 1 |
| Cédrin, I; Dodin, S; Faure, N; Guy, J; Lemay, A; Méchain, C; Turcot-Lemay, L | 1 |
| Wilson, L; Zemtsov, A | 1 |
| Bagnoli, A; Colombo, FM; Flamigni, C; Macrelli, S; Marescalchi, O; Paradisi, R; Ravaioli, B; Venturoli, S | 1 |
| Bloemena, E; Hage, JJ; Kanhai, RC; Mulder, JW; van Diest, PJ | 1 |
| Caruso, A; De Leo, V; Fulghesu, AM; la Marca, A; Morgante, G; Pasqui, L; Talluri, B; Torricelli, M | 1 |
| Breton, S; Fisher, JS; Pastor-Soler, N; Sharpe, RM | 1 |
| Carmina, E; Lobo, RA | 1 |
| Başogul, O; Inal, M; Ispahi, C; Karanfil, C; Onoglu, A; Taner, C; Tinar, S | 1 |
| de Zegher, F; Ibáñez, L | 3 |
| Kelestimur, F; Sahin, Y | 1 |
| Bahceci, M; Bahceci, S; Bilge, M; Tuzcu, A; Tuzcu, S | 1 |
| Cabré, S; De Zegher, F; Ibáñez, L; Valls, C | 1 |
| Al-Inany, H | 2 |
| Kawamura, S; Okuno, Y; Saito, K; Seki, T; Sukata, T; Sumida, K; Ueda, S; Yabushita, S; Yamada, T | 1 |
| Inal, MM; Taner, CE; Yildirim, Y | 1 |
| Hurst, MR; James, JD; Katsiadaki, I; Morris, S; Scott, AP; Squires, C | 1 |
| Bottero, S; Kloas, W; Lutz, I; Mandich, A; Urbatzka, R | 1 |
| Filby, AL; Maack, G; Thorpe, KL; Tyler, CR | 1 |
| Bottero, S; Cevasco, A; Kloas, W; Mandich, A; Massari, A; Pedemonte, F; Urbatzka, R | 1 |
| Balasch, J; Castelo-Branco, C; Gómez, O; Moyano, D | 1 |
| Aral, Y; Bavbek, N; Culha, C; Demirbas, B; Güler, S; Karakurt, F; Sahin, I; Serter, R | 1 |
| Breton, S; Brown, D; Fisher, JS; Hill, E; Pastor-Soler, NM; Sharpe, R; Van Hoek, A | 1 |
| De Zegher, F; Del Río, L; Díaz, M; Enríquez, G; Ibáñez, L; López-Bermejo, A | 1 |
| de Zegher, F; Díaz, M; Ibáñez, L; López-Bermejo, A | 1 |
| de Zegher, F; Diaz, M; Ibáñez, L; Lopez-Bermejo, A; Salvador, C; Sánchez-Infantes, D; Sebastiani, G | 1 |
| Chacón, MR; de Zegher, F; Díaz, M; Ibáñez, L; López-Bermejo, A; Maymó-Masip, E; Salvador, C; Vendrell, J | 1 |
| Bruni, V; Dei, M; Fambrini, M; Nannini, S; Peruzzi, E; Seravalli, V; Sisti, G | 1 |
| Açmaz, G; Boztosun, A; Müderris, II; Ozturk, A | 1 |
| Carter, B; Fedorowicz, Z; Pandis, N; van Zuuren, EJ | 1 |
| de Zegher, F; Díaz, M; Gallego-Escuredo, JM; Ibáñez, L; Villarroya, F | 1 |
| Canu, E; Fulghesu, AM; Melis, F; Melis, GB; Murru, G | 1 |
| Klems, JP; Luo, R; Markell, LK; Mingoia, RT; O'Connor, JC; Sayers, BC | 1 |
4 review(s) available for ethinyl estradiol and flutamide
| Article | Year |
|---|---|
Medical treatment regimens of hirsutism.
Topics: Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Enzyme Inhibitors; Ethinyl Estradiol; Female; Finasteride; Flutamide; Hirsutism; Humans; Hypoglycemic Agents; Metformin; Mineralocorticoid Receptor Antagonists; Spironolactone | 2004 |
Polycystic ovary syndrome.
Topics: Androgen Antagonists; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Finasteride; Flutamide; Hirsutism; Humans; Metformin; Polycystic Ovary Syndrome; Spironolactone | 2004 |
Polycystic ovary syndrome.
Topics: Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Finasteride; Flutamide; Humans; Metformin; Polycystic Ovary Syndrome; Spironolactone | 2005 |
Interventions for hirsutism (excluding laser and photoepilation therapy alone).
Topics: 5-alpha Reductase Inhibitors; Adult; Androgen Antagonists; Body Mass Index; Contraceptive Agents, Female; Cyproterone Acetate; Desogestrel; Drug Combinations; Eflornithine; Ethinyl Estradiol; Female; Finasteride; Flutamide; Hirsutism; Humans; Hypoglycemic Agents; Metformin; Quality of Life; Randomized Controlled Trials as Topic; Spironolactone | 2015 |
18 trial(s) available for ethinyl estradiol and flutamide
| Article | Year |
|---|---|
Treatment of hirsutism with flutamide and a low-dosage oral contraceptive in polycystic ovarian disease patients.
Topics: Adolescent; Adult; Contraceptives, Oral; Desogestrel; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethinyl Estradiol; Female; Flutamide; Gonadal Steroid Hormones; Hirsutism; Humans; Polycystic Ovary Syndrome; Treatment Outcome | 1994 |
Clinical efficacy and safety of low-dose flutamide alone and combined with an oral contraceptive for the treatment of idiopathic hirsutism.
Topics: Adult; Androgen Antagonists; Contraceptives, Oral, Hormonal; Drug Administration Schedule; Drug Therapy, Combination; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Flutamide; Gonadal Steroid Hormones; Hirsutism; Humans; Norgestrel; Prospective Studies | 1995 |
A prospective randomized trial comparing low dose flutamide, finasteride, ketoconazole, and cyproterone acetate-estrogen regimens in the treatment of hirsutism.
Topics: Adult; Cyproterone Acetate; Ethinyl Estradiol; Female; Finasteride; Flutamide; Hirsutism; Hormones; Humans; Ketoconazole; Prospective Studies | 1999 |
Hormonal and clinical effects of GnRH agonist alone, or in combination with a combined oral contraceptive or flutamide in women with severe hirsutism.
Topics: Adult; Amenorrhea; Androgen Antagonists; Contraceptives, Oral, Combined; Cyproterone Acetate; Estradiol; Estradiol Congeners; Estrone; Ethinyl Estradiol; Female; Flutamide; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Hirsutism; Humans; Luteinizing Hormone; Luteolytic Agents; Polycystic Ovary Syndrome; Progesterone Congeners; Prospective Studies; Triptorelin Pamoate | 2000 |
Treatment of hyperandrogenic alopecia in women.
Topics: 5-alpha Reductase Inhibitors; Adult; Alopecia; Androgen Antagonists; Cyproterone Acetate; Dehydroepiandrosterone Sulfate; Enzyme Inhibitors; Ethinyl Estradiol; Female; Finasteride; Flutamide; Humans; Hyperandrogenism; Italy; Liver; Testosterone | 2003 |
Comparison of the clinical efficacy and safety of flutamide versus flutamide plus an oral contraceptive in the treatment of hirsutism.
Topics: Administration, Oral; Adult; Androgen Antagonists; Contraceptives, Oral; Cyproterone Acetate; Dehydroepiandrosterone Sulfate; Drug Administration Schedule; Drug Therapy, Combination; Ethinyl Estradiol; Female; Flutamide; Hirsutism; Humans; Liver Function Tests; Prolactin; Severity of Illness Index; Testosterone; Treatment Outcome | 2002 |
Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity.
Topics: Adiponectin; Adipose Tissue; Adolescent; Adult; Androgen Antagonists; Androstenes; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Flutamide; Hormone Antagonists; Humans; Hyperandrogenism; Hyperinsulinism; Hypoglycemic Agents; Intercellular Signaling Peptides and Proteins; Interleukin-6; Metformin; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Proteins | 2004 |
Flutamide-metformin plus an oral contraceptive (OC) for young women with polycystic ovary syndrome: switch from third- to fourth-generation OC reduces body adiposity.
Topics: Abdomen; Adipose Tissue; Adolescent; Adult; Androgen Antagonists; Contraceptives, Oral; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Flutamide; Humans; Hypoglycemic Agents; Metformin; Norpregnenes; Obesity; Polycystic Ovary Syndrome | 2004 |
Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of early, low-dose flutamide.
Topics: Adiponectin; Adolescent; Androstenes; Arteriosclerosis; Drug Therapy, Combination; Ethinyl Estradiol; Female; Flutamide; Humans; Hyperandrogenism; Intercellular Signaling Peptides and Proteins; Interleukin-6; Lipolysis; Metformin; Polycystic Ovary Syndrome; Proteins | 2004 |
Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of metformin at the start and after more than one year of therapy.
Topics: Adolescent; Adult; Androstenes; Arteriosclerosis; Drug Therapy, Combination; Ethinyl Estradiol; Female; Flutamide; Humans; Hyperandrogenism; Lipolysis; Metformin; Polycystic Ovary Syndrome; Time Factors | 2005 |
Comparison of the clinical efficacy of flutamide and spironolactone plus Diane 35 in the treatment of idiopathic hirsutism: a randomized controlled study.
Topics: Adult; Androgen Antagonists; Cyproterone Acetate; Diuretics; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Flutamide; Hirsutism; Humans; Polycystic Ovary Syndrome; Prospective Studies; Spironolactone; Treatment Outcome | 2005 |
Long-term safety and tolerability of flutamide for the treatment of hirsutism.
Topics: Adult; Androgen Antagonists; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Flutamide; Follow-Up Studies; Hirsutism; Humans; Time Factors; Treatment Outcome; Young Adult | 2009 |
Comparison of the clinical efficacy of flutamide and spironolactone plus ethinyloestradiol/cyproterone acetate in the treatment of hirsutism: a randomised controlled study.
Topics: Adult; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Flutamide; Hirsutism; Humans; Lipids; Prospective Studies; Spironolactone; Young Adult | 2008 |
Low-dose pioglitazone, flutamide, metformin plus an estro-progestagen for non-obese young women with polycystic ovary syndrome: increasing efficacy and persistent safety over 30 months.
Topics: Adolescent; Alanine Transaminase; Androgens; Androstenes; Aspartate Aminotransferases; Blood Glucose; Body Composition; C-Reactive Protein; Cholesterol; Cross-Over Studies; Drug Therapy, Combination; Ethinyl Estradiol; Female; Flutamide; gamma-Glutamyltransferase; Humans; Hydro-Lyases; Insulin; Longitudinal Studies; Metformin; Pioglitazone; Polycystic Ovary Syndrome; Thiazolidinediones; Tunica Intima; Young Adult | 2010 |
Divergent effects of ethinylestradiol-drospirenone and flutamide-metformin on follistatin in adolescents and women with hyperinsulinemic androgen excess.
Topics: Adolescent; Androgen Antagonists; Androstenes; Body Composition; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Female; Flutamide; Follistatin; Humans; Hyperandrogenism; Hyperinsulinism; Metformin; Young Adult | 2011 |
Treatment of androgen excess in adolescent girls: ethinylestradiol-cyproteroneacetate versus low-dose pioglitazone-flutamide-metformin.
Topics: Abdominal Fat; Adolescent; Androgen Antagonists; Body Composition; Cyproterone Acetate; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Flutamide; Humans; Hyperandrogenism; Hyperinsulinism; Hypoglycemic Agents; Metformin; Pioglitazone; Thiazolidinediones; Treatment Outcome | 2011 |
Ethinyl estradiol-cyproterone acetate versus low-dose pioglitazone-flutamide-metformin for adolescent girls with androgen excess: divergent effects on CD163, TWEAK receptor, ANGPTL4, and LEPTIN expression in subcutaneous adipose tissue.
Topics: Abdominal Fat; Adolescent; Androgen Antagonists; Angiopoietin-Like Protein 4; Angiopoietins; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Body Composition; Cyproterone Acetate; Dose-Response Relationship, Drug; Drug Combinations; Ethinyl Estradiol; Female; Flutamide; Gene Expression; Humans; Hyperandrogenism; Hypoglycemic Agents; Leptin; Metformin; Pioglitazone; Receptors, Cell Surface; Receptors, Tumor Necrosis Factor; Subcutaneous Fat; Thiazolidinediones; TWEAK Receptor | 2012 |
Effects of ethinylestradiol-cyproterone acetate vs. pioglitazone-flutamide-metformin on plasma FGF21 levels in adolescent girls with androgen excess.
Topics: Adolescent; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Fibroblast Growth Factors; Flutamide; Hirsutism; Humans; Hyperandrogenism; Hyperinsulinism; Longitudinal Studies; Metformin; Pioglitazone; Thiazolidinediones | 2016 |
26 other study(ies) available for ethinyl estradiol and flutamide
| Article | Year |
|---|---|
Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-beta ligands.
Topics: Androgen Antagonists; Animals; Animals, Genetically Modified; Anti-Inflammatory Agents, Non-Steroidal; Binding Sites; Body Temperature; Bone Diseases, Metabolic; Cell Line, Tumor; Crystallography, X-Ray; Drug Design; Estrogen Receptor beta; Female; HLA-B27 Antigen; Humans; Isoxazoles; Male; Mice; Models, Molecular; Organ Size; Phenols; Prostate; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Structure-Activity Relationship; Transcription, Genetic; Uterus | 2004 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Potent and selective steroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 7, an enzyme that catalyzes the reduction of the key hormones estrone and dihydrotestosterone.
Topics: 17-Hydroxysteroid Dehydrogenases; Androstane-3,17-diol; Androstanes; Biocatalysis; Cell Line; Dihydrotestosterone; Enzyme Inhibitors; Estradiol; Estrone; Humans; Inhibitory Concentration 50; Oxidation-Reduction; Substrate Specificity | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Combination of GSH trapping and time-dependent inhibition assays as a predictive method of drugs generating highly reactive metabolites.
Topics: Glutathione; Pharmacology; Sulfur Radioisotopes | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Steroidal actions and voluntary drinking of ethanol by male and female rats.
Topics: Alcohol Dehydrogenase; Alcohol Drinking; Alcohol Oxidoreductases; Aldehyde Dehydrogenase; Aldehyde Oxidoreductases; Animals; Estradiol; Estrogen Antagonists; Estrogens; Ethinyl Estradiol; Female; Flutamide; Liver; Male; Rats; Rats, Inbred Strains; Tamoxifen | 1981 |
Successful treatment of hirsutism in HAIR-AN syndrome using flutamide, spironolactone, and birth control therapy.
Topics: Acanthosis Nigricans; Adolescent; Androgen Antagonists; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Ethynodiol Diacetate; Female; Flutamide; Hirsutism; Humans; Hyperandrogenism; Insulin Resistance; Remission Induction; Spironolactone; Syndrome | 1997 |
Short-term and long-term histologic effects of castration and estrogen treatment on breast tissue of 14 male-to-female transsexuals in comparison with two chemically castrated men.
Topics: Adult; Aged; Androgen Antagonists; Anilides; Breast; Castration; Cyproterone Acetate; Estradiol Congeners; Ethinyl Estradiol; Female; Flutamide; Follow-Up Studies; Gynecomastia; Humans; Male; Mastectomy, Subcutaneous; Metaplasia; Nitriles; Orchiectomy; Time Factors; Tosyl Compounds; Transsexualism | 2000 |
Modulation of the onset of postnatal development of H(+)-ATPase-rich cells by steroid hormones in rat epididymis.
Topics: Aging; Androgen Antagonists; Animals; Animals, Newborn; Blotting, Western; Cell Count; Diethylstilbestrol; Epididymis; Ethinyl Estradiol; Fluorescent Antibody Technique; Flutamide; Gonadotropin-Releasing Hormone; Hormones; Male; Organ Size; Proton-Translocating ATPases; Rats; Rats, Wistar; Testis; Testosterone | 2002 |
Serum prostate specific antigen levels in women with polycystic ovary syndrome and the effect of flutamide+desogestrel/ethinyl estradiol combination.
Topics: Adolescent; Adult; Androgen Antagonists; Androgens; Androstenedione; Contraceptives, Oral, Hormonal; Desogestrel; Drug Therapy, Combination; Ethinyl Estradiol; Female; Flutamide; Hirsutism; Humans; Insulin; Luteinizing Hormone; Polycystic Ovary Syndrome; Prostate-Specific Antigen; Testosterone | 2004 |
Functional genomics may allow accurate categorization of the benzimidazole fungicide benomyl: lack of ability to act via steroid-receptor-mediated mechanisms.
Topics: Administration, Oral; Animals; Benomyl; Benzimidazoles; Biological Assay; Carbamates; Dichlorodiphenyl Dichloroethylene; Dose-Response Relationship, Drug; Down-Regulation; Estrogen Receptor alpha; Ethinyl Estradiol; Female; Flutamide; Fungicides, Industrial; Gene Expression; Gene Expression Profiling; Genes, Reporter; Genomics; HeLa Cells; Humans; Luciferases; Male; Microtubules; Orchiectomy; Organ Size; Rats; Rats, Sprague-Dawley; Receptors, Androgen; Testosterone Propionate; Uterus | 2005 |
Use of the three-spined stickleback (Gasterosteus aculeatus) as a sensitive in vivo test for detection of environmental antiandrogens.
Topics: Angiogenesis Inhibitors; Animals; Dihydrotestosterone; Environmental Exposure; Ethinyl Estradiol; Female; Fish Proteins; Flutamide; Kidney; Male; Methyltestosterone; Models, Animal; Osmolar Concentration; Seasons; Smegmamorpha | 2006 |
Endocrine disrupters with (anti)estrogenic and (anti)androgenic modes of action affecting reproductive biology of Xenopus laevis: I. Effects on sex steroid levels and biomarker expression.
Topics: Androgen Antagonists; Androgens; Animals; Biomarkers; Dihydrotestosterone; Endocrine Disruptors; Estradiol; Estrogen Antagonists; Estrogens; Ethinyl Estradiol; Female; Flutamide; Italy; Male; Prealbumin; Retinol-Binding Proteins; Retinol-Binding Proteins, Plasma; Rivers; RNA, Messenger; Tamoxifen; Testosterone; Transferrin; Vitellogenins; Water Pollutants, Chemical; Xenopus laevis | 2007 |
Gene expression profiles revealing the mechanisms of anti-androgen- and estrogen-induced feminization in fish.
Topics: Androgen Antagonists; Animals; Cyprinidae; Ethinyl Estradiol; Female; Feminization; Flutamide; Gene Expression; Gene Expression Profiling; Gonads; Hormones; Liver; Male; Receptors, Androgen; Receptors, Estrogen; Reproduction; Reverse Transcriptase Polymerase Chain Reaction; Sex Characteristics; Vitellogenins; Water Pollutants, Chemical | 2007 |
Endocrine disrupting chemicals (EDC) with (anti)estrogenic and (anti)androgenic modes of action affecting reproductive biology of Xenopus laevis: II. Effects on gonad histomorphology.
Topics: Animals; Endocrine Disruptors; Environmental Monitoring; Ethinyl Estradiol; Female; Flutamide; Male; Methyltestosterone; Ovary; Tamoxifen; Testis; Xenopus laevis | 2008 |
Aquaporin 9 expression in the developing rat epididymis is modulated by steroid hormones.
Topics: Animals; Animals, Newborn; Aquaporins; Diethylstilbestrol; Drug Combinations; Epididymis; Ethinyl Estradiol; Flutamide; Gonadal Steroid Hormones; Gonadotropin-Releasing Hormone; Hormone Antagonists; Male; Rats; Rats, Wistar; Testosterone | 2010 |
Hepatotoxicity with low- and ultralow-dose flutamide: a surveillance study on 203 hyperandrogenic young females.
Topics: Adolescent; Adult; Alanine Transaminase; Androgen Antagonists; Aspartate Aminotransferases; Biomarkers; Chemical and Drug Induced Liver Injury; Contraceptives, Oral; Dose-Response Relationship, Drug; Drug Combinations; Ethinyl Estradiol; Female; Flutamide; Humans; Hyperandrogenism; Norpregnenes; Population Surveillance; Risk Factors; Young Adult | 2012 |
Clinical efficacy of low dose flutamide plus Diane-35 in the treatment of idiopathic hirsutism and polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Cyproterone Acetate; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Flutamide; Hirsutism; Humans; Polycystic Ovary Syndrome; Severity of Illness Index; Treatment Outcome; Women's Health; Young Adult | 2013 |
Very low dose of flutamide in the treatment of hyperandrogenism.
Topics: Acne Vulgaris; Adolescent; Androgen Antagonists; Androstenes; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethinyl Estradiol; Female; Flutamide; Hirsutism; Humans; Hyperandrogenism; Norpregnenes; Treatment Outcome; Young Adult | 2018 |
Evaluation of dietary dose administration as an alternative to oral gavage in the rodent uterotrophic and Hershberger assays.
Topics: Administration, Oral; Androgen Antagonists; Animals; Biological Assay; Diet; Estrogens; Ethinyl Estradiol; Eugenol; Female; Flutamide; Genitalia, Male; Linuron; Male; Organ Size; Rats; Uterus | 2021 |